Pancreatic Cancer Drug Doubles Survival Time in Trial

A groundbreaking new drug nearly doubled survival time for people with advanced pancreatic cancer, marking the biggest treatment advance in over a decade.

The success is sparking hope that other hard-to-treat cancers could soon follow.